So you have a bad LiPo battery
The observation that the induced effect on insulin secretion is different when oral glucose was administered versus the same amount of glucose parenterally coined the term incretin effect, supporting the idea that some substances secreted in the intestines favored the release of insulin after ingestion [1]
Cardiovascular Benefits : The SELECT trials demonstration of cardiovascular risk reduction in non-diabetic obese patients represents a paradigm shift, establishing GLP-1 agonists as potentially life-saving interventions beyond weight loss
Abstract Introduction We assessed the effect of the prandial state on the pharmacokinetics, safety, and tolerability of single and multiple doses of orforglipron (LY3502970), an oral, non-peptide glucagon-like peptide 1 receptor agonist (GLP-1 RA), in two studies (A and B)
[5] It is speculated that Tesamorelin & Mod GRF may stimulate the production of cyclic adenosine monophosphate (cAMP) within the target cells
X-ray crystal structure of a recombinant human myoglobin mutant at 2.8 A resolution